ImmunoPrecise Antibodies Ltd. (IPA) is a global biotechnology firm that, through its subsidiaries, focuses on the development and production of antibodies, alongside offering a broad spectrum of related scientific services. Its operational footprint spans across the United States, Canada, Europe, Australia, and other international territories. For the research community, IPA delivers a diverse portfolio of products, including various types of antibodies, enzymes, enzyme activity assays, specialized animal products for arthritis studies, proteins (such as deiminated proteins), organoid growth factors, and hybridoma reagents.